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Abstract
Background: Endogenous nitric oxide (NO) kills bacteria and other organisms as part of the innate immune
response. When nitrite is exposed to low pH, NO is generated and has been used as an NO delivery system to
treat skin infections. We demonstrated eradication of MRSA carriage from wounds using a topical formulation of
citric acid (4.5%) and sodium nitrite (3%) creams co-applied for 5 days to 15 wounds in an observational
prospective pilot study of 8 patients.
Findings: Following treatment with topical citric acid and sodium nitrite, 9 of 15 wounds (60%) and 3 of 8 patients
(37%) were cleared of infection. MRSA isolates from these patients were all sensitive to acidified nitrite in vitro
compared to methicillin-sensitive S. aureus and a reference strain of MRSA.
Conclusions: Nitric oxide and acidified nitrite offer a novel therapy for control of MRSA in wounds. Wounds that
were not cleared of infection may have been re-contaminated or the bioavailability of acidified nitrite impaired by
local factors in the tissue.
Background
The widespread clinical use of antibiotics over the last 50
years has led to the emergence of resistant strains [1].
Methicillin-resistant Staphylococcus aureus (MRSA) was
first noted in Great Britain in the early 60 s [2]. MRSA is a
major cause of infections in humans worldwide, in both
the community and the hospital [3]. Following targeted
action, the incidence of MRSA bacteraemia has been fall-
ing since 2006 in the UK [3]. However, it still remains a
considerable problem throughout Europe [4]. Surgical
wounds are frequently colonised or significantly infected
with MRSA [5]. MRSA is a major cause of surgical site
infection which can delay hospital discharge [6]. In
another study 23% of diabetic foot ulcers were infected
[7]. MRSA infections are also a frequent cause of abscesses
[8] and novel or better bactericidal agents that can be
applied to wounds for decolonisation or prevention are
urgently needed [9].
Acidified nitrite was devised as a novel means of liber-
ating the bactericidal gas nitric oxide (NO) on the skin
as a topical antibiotic therapy [10-12]. Briefly nitrite and
hydrogen ions form nitrous acid (1) which is converted
to dinitrogen trioxide (2), which dissociates into nitric
oxide and nitrous oxide (3).
NO2− + H
+  HNO2 (1)
2HNO2  H2O + N2O3 (2)
N2O3  NO + NO2 (3)
We found that Trichophyton mentagrophytes,
T. rubrum, Candida albicans, Streptococcus pyogenes,
S. aureus and Propionibacterium acnes are all sensitive to
acidified nitrite [12], with S. aureus being particularly
sensitive. In the clinic, the concept of combining topical
treatment with a nitrite containing cream and an acidic
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cream as a means of topical NO therapy has been proven
[11,10] and used to treat Mycobacterium ulcerans caus-
ing Buruli ulcer [13] by co-application of creams contain-
ing 6% sodium nitrite and 9% citric acid.
As topical NO combining 3.0% (w/v) sodium nitrite
and 4.5% (w/v) citric acid also facilitates experimental
wound healing [14] it is an excellent candidate for
decontaminating infected wounds. We hypothesised that
acidified nitrite would be a useful agent in eliminating
MRSA infection from the skin and aimed to demon-
strate its ability to inhibit and kill MRSA in vitro and in
a clinical plot study.
Methods
Subjects
We recruited hospitalised patients with a positive MRSA
wound culture. Pregnant and lactating females and those
with carriage of MRSA cultured from nose, axilla, groins,
throat or sputum were excluded from the study to avoid
recontamination of the wound. Patients taking systemic
antibiotics or demonstrating additional pathogens in the
wound swabs were also excluded.
Initial swabs of the nose, throat, axillae, perineum and
any unhealed wounds were taken to assess eligibility for
the study. These were all repeated in a routine fashion by
the nursing staff in accordance with well defined infec-
tion control protocols at baseline, day five of treatment
and two and four days after stopping topical acidified
nitrite therapy to assess recurrence of infection. Those
who developed nasal carriage during the study were trea-
ted with nasal applications of mupirocin.
Intervention
Treatment was applied to the infected wound twice daily
for 5 days. Trained nursing staff co-applied equal amounts
of 4.5% citric acid in aqueous cream and 3% sodium nitrite
in aqueous cream mixed directly on the infected wound
and surrounding skin which was then covered with a light
gauze dressing. Once daily dressings were changed using
aseptic technique, wounds were irrigated with sterile saline
and the cream and a sterile dressing reapplied.
Safety
Acidified nitrite has been used safely in previous studies
[11,13,15,16]. Citric acid and sodium nitrite were chosen
as having optimum stability and safety for use in humans,
citric acid being a naturally occurring agent in the diet and
an approved ingredient in cosmetics and skin care pro-
ducts. Sodium nitrite also occurs naturally in the diet in
vegetables and meat and is a permitted food preservative,
but systemic doses of 4.5 g are sufficient to kill a human
through methaemoglobinaemia. There have also been con-
cerns about systemic formation of N-nitrosothiols which
may have carcinogenic potential in the gut [17]. The
concentrations of sodium nitrite and citric acid used
represent a 2:1 molar ratio of sodium nitrite to citric acid
to ensure sufficient acid is available to react with the
nitrite to prevent residual nitrite being systemically
absorbed leading to methaemoglobinaemia. Citric acid
and sodium nitrite have been used safely for topical appli-
cation to the skin up to 9 and 13.5% twice daily for up to
4 months in unpublished studies (Pro-Strakan data on file)
and on ulcerated skin has been used safely in humans up
to 9% and 6% respectively in a published study [18], where
positive effects on wound healing were observed. Two
year carcinogenicity studies have been performed on 330
mice without significant oncogenesis. In pilot studies and
Phase 1&II studies in man over 700 subjects have received
skin treatment with concentrations of acidified nitrite of
up to 9% sodium nitrite and 13.5% citric acid for up to 3-4
months with no treatment related serious adverse events
and only mild skin irritation and staining occurring as side
effects (Pro-Strakan data on file).
MRSA Screening
All clinical samples were processed by standard culture
methods on horse blood agar and MacConkey agar. Sus-
pect colonies were confirmed as S.aureus by the slide coa-
gulase test (Staph latex kit; Prolex Neston UK) and by the
antibiogram using Clinical and Laboratory Standards Insti-
tute. Surveillance samples were processed by enrichment
and culture. Swabs were placed in nutrient broth (Oxoid,
Baskingstoke, UK) supplemented with 10% salt and incu-
bated in ambient air for 18-24 hours. The broth was then
subcultured on to Columbia agar (Oxoid) supplemented
with 4 mg/L methicillin and incubated for a further
18-24 h in ambient air. All suspect colonies from surveil-
lance swabs were confirmed as MRSA by the slide coagu-
lase test and antibiogram [19].
Typing of isolates
The first MRSA isolate from each subject was used for in
vitro testing and was phenotyped by the Scottish MRSA
reference library using PCR and pulsed field gel electro-
phoresis. The phenotypes of the seven MRSA strains
were again confirmed using coagulase, DNAase and
methicillin susceptibility tests. The coagulase test was
performed according the instruction of ProlexTM Staph
Latex Kit (Pro-Lab Diagnostics, UK). For the DNASE
test, overnight cultures were spotted onto DNASE agar
(Oxoid, UK) and incubated for 37°C for 24 hours. A clear
zone around the colony indicated MRSA positive strains.
The methicillin susceptibility test was conducted whereby
an ME E-test strip (Cambridge Diagnostic Services Ltd.
UK) was placed on the surface of the agar freshly
swabbed with the test strain. After incubation of the agar
at 30°C for 24 hours, the methicillin-induced inhibition
zone was recorded.
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In vitro sensitivity
All MRSA bacterial strains and an MSSA reference
strain were grown in either nutrient broth (Sigma-
Aldrich) or on nutrient agar (1.5% w/v) at 37°C. To
determine the antimicrobial activity of acidified nitrite,
using HCl as the acid, the assay was performed as
described previously [12,20,21]. In brief, the pH of the
nutrient broth was adjusted with HCl as this was pre-
viously standardized as an assay to create a pH gradient
ranging from 1.7 to 7.0 across a micro-titre plate. To
achieve a gradient of acidified nitrite, a gradient of
potassium nitrite ranging from 0 to 10000 μM was then
set up along the length of the micro-titre plate. For all
experiments, 8 × 107 cells ml-1 of a stationary phase
culture of each strain was used as an inoculum. The
micro-titre plate was then incubated at 37*C, 90 rpm
and after the designated time, 20 μl aliquots were
removed, serially diluted and colony forming units
determined by assessing growth on nutrient agar after
an overnight incubation at 37°C. The inhibitory effect of
acidified nitrite on bacterial growth was determined by
measurement of optical density (570 nm) (MRX Micro-
plate Reader, Dynatech) after 24 hours. The minimum
inhibition concentration (MIC) for each strain were
determined as the average values from 5 replicates. The
MIC of acidified nitrite was defined as the lowest nitrite
concentration whereby no growth of the strains had
taken place at a certain pH after 24 hours.
The protocol was approved by the local Grampian
Combined Ethical Committee and Infection Control
Committees.
Results
Patients meeting the entry criteria with MRSA colonisa-
tion confined to a wound, with negative swabs elsewhere
were rare. Recruiting from an acute hospital with over
1000 beds over 18 months, this limited the study to 8
patients, 6 of whom had more than one colonised wound
giving a total of 15 infected wounds. Their clinical details
are summarised in table 1. These patients were all treated
at the wound sites only with 4.5% citric acid co-adminis-
tered with 3% sodium nitrite for 5 consecutive days.
Swabs were regularly performed from wounds and from
other skin sites (see methods). Application of acidified
nitrite at these concentrations was well tolerated by all
subjects and there was no irritation of the skin noted or
increase in pain from the wounds.
Following treatment, three patients were completely
cleared of their wound infection without recurrence after
a further 4 days. Three showed a partial response (clear-
ance of one wound) and two failed to respond. Of the 15
infected wounds 9 (60%) were cleared of MRSA colonisa-
tion. Of wounds that responded only 2/9(22%) were
necrotic and non-responders were necrotic in 4/6(66%)
this difference was not statistically significant (Fisher’s
exact test).
Although precautions were taken to cover the wounds
and use sterile technique when the dressings were chan-
ged, re-contamination could occur when dressings were
changed or when wetted in the shower. Non-response
might also be explained by such recontamination from
untreated areas of the patient or close environment. This
is supported by the observation that 3 patients developed
positive swabs from other previously negative untreated
body sites during the study. Four of 7 (57%) of wounds
still colonised or recolonised at day 9 occurred in
patients with other sites becoming positive while 8 of 8
(100%) of wounds that remained clear occurred in
patients not becoming positive at other sites (p = 0.077
Fisher’s exact test).
The first isolate from each patient was used to confirm
the phenotype of the MRSA isolate and for In vitro testing
(Table 2). These showed similar or greater in vitro sensi-
tivity to MSSA as measured by MIC at identical pH and
nitrite concentrations (Figure 1). As with the MIC analysis,
we found that the minimum bactericidal concentration
(MBC) of NO2
- was reduced as the pH of the medium was
lowered. In addition, we found that the average MBC to
acidified nitrite for the seven MRSA strains was slightly
lower than for the MSSA strain, indicating that MRSA
strains do not have increased resistance to acidified nitrite.
This was particularly evident at pH 4.5, since no killing of
the MSSA strain was observed after 2 hours using the
maximum concentration of sodium nitrite used in our
assay (Figure 2); in contrast, the MRSA strains were still
killed under these conditions.
No adverse effects of the acidified nitrite were
reported in this small pilot study.
Discussion
These pilot results highlight the potential efficacy of acid-
ified nitrite as a topical therapy for MRSA. Considering
the lack of an effective therapy in this clinical setting it
potentially represents a significant therapeutic advance.
Wounds are unlikely to become clear of infection sponta-
neously. Strains isolated from infected wounds showed in
vitro sensitivity to acidified nitrite which supports the
clinical findings. Indeed, preliminary data suggested that
the MRSA strains possibly more sensitive to acidified
nitrate than the MSSA strain tested. However, further
studies analysing different MSSA strains would be neces-
sary to confirm that this was the case and not due to the
individual MSSA strain tested.
Given that there was no difference in the MICs between
MRSA isolates from the different subjects, it is unlikely
that specific resistance to acidified nitrite could explain
failure to clear. Indeed isolate 8 was more sensitive than
MSSA in vitro and cleared from only one of two wounds
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Table 1 Clinical details and outcomes of wound cultures from subjects treated with acidified nitrite where more than one wound was treated this is shown a
several rows
Age Sex Immuno-supressed Strain tested in vitro Wounds Necrosis Cultures from wound day: Other sites becoming positive
0 5 7 9
84 M No 3 Gangrene toe Yes + + + + No
90 F No 4 Amputation No + - - - No
83 F Prednisolone azathioprine 5 Vasculitic
Leg ulcers
Yes + + + + No
+ + - -
85 M No 6 Orthopaedic pin sites No + - - - No
+ - - -
74 F No 7 Pressure sores No + + + + Yes Axilla
(day 5)
+ + + +
74 M No 8 Orthopaedic pin sites No + - - - No
+ + + +
79 F Prednisolone Not tested Infected blisters No + - - - No
+ - - -
+ - - -
68 F Renal failure Not tested Calciphylaxis ulcers on legs Yes + - - + Yes groins
(day 7)
+ + + +
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suggesting that local factors were responsible. Failure to
clear some infected wounds may be due to recontamina-
tion from other infected sites as demonstrated in the
patient with renal failure. She cleared at one of 2 sites on
the legs and the cleared site was re-infected as was a groin
swab after 9 days. In all other wounds that cleared, clinical
response was maintained to day nine, four days after stop-
ping treatment. Successful treatment was more common
in patients who did not have positive swabs at other sites.
Finally, wounds that did not clear of MRSA were more
frequently associated with tissue necrosis. Topical therapy
may not have penetrated a thick eschar. Better bioavail-
ability may result from doubling the concentrations of
acid and nitrite which have been used in the treatment of
Buruli ulcers [13].
When acid and nitrite are mixed they react together to
release nitric oxide (NO) and nitrous oxide (NO2). These
gases may be irritant to the airways and mucosal surfaces
so we avoided treating infections of the nose and limited
this study to infections on limited “target” areas of the
skin and wounds. As NO is a gas with similar physical
properties to oxygen, it can diffuse readily into the skin
or a wound to treat the infection and does so more read-
ily than conventional antibiotics.
Previous studies in other micro-organisms [12,21] infer
that NO is responsible for the effects seen on organisms.
Ghaffari demonstrated that exposure to 200 ppm of NO
gas for 5 hours was equally bactericidal to S. aureus,
MRSA, Escherichia coli, Group B Streptococcus, Pseudomo-
nas aeruginosa, and Candida albicans while NO2 was not
effective [22]. This also suggests that NO is responsible for
killing the organism. Ghaffari went on to demonstrate that
gaseous NO therapy reduced bacterial counts in experi-
mental staphylococcal skin infections without impairing
angiogenesis or wound healing [23]. Miller et al exposed
cultures of S. aureus to eight sub-lethal exposures of NO
Table 2 Typing of isolates
Strain Coagulase test DNASE test Methicillin susceptibility test* Reference lab
MRSA
Phenotype
MRSA Genotype
3 + + - EMRSA 16 variant phage type PF16d
4 + + - EMRSA 16 PF16a
5 + + - EMRSA 16 PF16a
6 + + - EMRSA 16 PF16a
7 + + - EMRSA 16 PF16a
8 + + - EMRSA 16 variant phage type PF16d
9 (MRSA) control + + - **
1 (MSSA) control + + + **
* no inhibition zone up to 256 μg/ml for all MRSA strains
** not done
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Figure 1 The effect of pH on the minimum inhibitory concentration of nitrite. The average minimum inhibitory concentrations (MICs) of
nitrite for the MSSA control strain (1), a previously typed MRSA control strain (9) and seven MRSA strains (2-8) isolated from the wounds of
patients were determined at either pH 4.5, 5.0 or 5.5, using HCl to acidify. The MICs values shown are an average of five independent
determinations for each strain and the arrows indicate that pH 4.5 alone was inhibitory to the strains.
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in order to select for resistant organisms. However, sensi-
tivity was preserved compared to control organisms
exposed only to pure air [24]. The precise mechanism
whereby NO is bactericidal is not understood but Marti-
nez’s recent study examined staphylococci by electron
microscopy and observed cellular oedema after 1 hr expo-
sure, increasing destruction of the cell wall architecture
after 7 hours, followed by lysis of cells after 24 hours using
a nanoparticle technology to deliver NO [25]. Martinez
et al[25] induced wounds in mice and inoculated these
with MRSA. Bacteriological burden measured by culture
and by gram staining was significantly reduced with 2
applications of NO nanoparticles after 4 and 7 days
respectively [25].
The wide range of infections sensitive to acidified nitrite
suggest that this would be a useful addition to the preven-
tion and therapy of MRSA and to wound care, especially
where several organisms are responsible. There have been
no reports of bacteria becoming completely resistant to
acidified nitrite, although nitrite has been used for a very
long time as a food preservative so organisms have been
exposed to this agent.
Limitations of this study
As it was difficult to find subjects meeting the entry cri-
teria of infection confined to a wound, numbers of sub-
jects are small. The study also lacked controls or
randomisation to prove that the intervention was responsi-
ble for the clearing of infection. Finally the concept of sub-
jects having infection confined to a contaminated wound
was likely to be erroneous and standardised swabbing
protocols do not exclude carriage of MRSA in the patients’
intact skin or immediate environment. Infected wounds
that did not clear of MRSA did not have resistant infection
but were likely to have been recontaminated or alterna-
tively the bioavailability of acidified nitrite was impaired.
Conclusions
Acidified nitrite is a potential novel therapy for topical
application, which can kill MRSA without irritating the
skin; this could have important applications in the treat-
ment of localised skin infections, wounds and in the
decontamination of hospital staff and merits further study.
List of abbreviations
MIC: Minimum inhibitory concentration; MBC: Minimum Bactericidal
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